Phase II Study of Daily Sunitinib in FDG-PET–Positive, Iodine-Refractory Differentiated Thyroid Cancer and Metastatic Medullary Carcinoma of the Thyroid with Functional Imaging Correlation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase II Study of Daily Sunitinib in FDG-PET–Positive, Iodine-Refractory Differentiated Thyroid Cancer and Metastatic Medullary Carcinoma of the Thyroid with Functional Imaging Correlation

Published:2010-09-16 Issue:21 Volume:16 Page:5260-5268
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Carr Laurie L.,Mankoff David A.,Goulart Bernardo H.,Eaton Keith D.,Capell Peter T.,Kell Elizabeth M.,Bauman Julie E.,Martins Renato G.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 363 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Era of Advances in Systemic Therapies for Advanced Thyroid Cancer;JCO Oncology Practice;2024-07

2. RET kinase inhibitors for the treatment of RET-altered thyroid cancers: Current knowledge and future directions;Annales d'Endocrinologie;2024-04

3. Positron Emission Tomography/Computed Tomography in Thyroid Cancer;PET Clinics;2024-04

4. Unraveling the Promise of RET Inhibitors in Precision Cancer Therapy by Targeting RET Mutations;Journal of Medicinal Chemistry;2024-03-14

5. La PET/TC nell’era degli agenti citostatici: ruolo nella valutazione della risposta alla terapia con inibitori della tirosin-chinasi (TKI) nel carcinoma tiroideo;L'Endocrinologo;2024-01-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP